Skip to main content

Advertisement

ADVERTISEMENT

Exclusives

News
02/20/2024
A 30-patient study will evaluate the safety of the investigational device, Regenn Negative Pressure Therapy System, in post-op surgical wounds. The primary outcome measure is device-related serious adverse event rate and the estimated study...
A 30-patient study will evaluate the safety of the investigational device, Regenn Negative Pressure Therapy System, in post-op surgical wounds. The primary outcome measure is device-related serious adverse event rate and the estimated study...
A 30-patient study will evaluate...
02/20/2024
Wound Care
News
02/20/2024
Kent Imaging and APEX Health Network are partnering to integrate Snapshot into the network of Limb Preservation Centers. The vascular imaging technology will be used by a multidisciplinary team of limb preservation physicians to prevent...
Kent Imaging and APEX Health Network are partnering to integrate Snapshot into the network of Limb Preservation Centers. The vascular imaging technology will be used by a multidisciplinary team of limb preservation physicians to prevent...
Kent Imaging and APEX Health...
02/20/2024
Wound Care
News
02/20/2024
Cinesteam shared that their dressing is intended for the management of malodorous wounds and is applied as a secondary dressing. Cinesteam is a cinnamon-based dressing, sold OTC and owned by Cemag Care, a French pharmaceutical company based...
Cinesteam shared that their dressing is intended for the management of malodorous wounds and is applied as a secondary dressing. Cinesteam is a cinnamon-based dressing, sold OTC and owned by Cemag Care, a French pharmaceutical company based...
Cinesteam shared that their...
02/20/2024
Wound Care
News
02/20/2024
A study assessed the healthcare utilization of patients with chronic venous insufficiency-associated lymphedema (CVI-LED). Of the 85,601 LED patients identified, 8,406 also had CVI. The use of LED-specific therapy before and after venous...
A study assessed the healthcare utilization of patients with chronic venous insufficiency-associated lymphedema (CVI-LED). Of the 85,601 LED patients identified, 8,406 also had CVI. The use of LED-specific therapy before and after venous...
A study assessed the healthcare...
02/20/2024
Wound Care
News
02/12/2024
An international panel of 20 ortho surgeons reached a consensus on 18 statements pertaining to wound closure and incision management in THA procedures. One notable recommendation cited for at-risk patients was the use of NPWT over other...
An international panel of 20 ortho surgeons reached a consensus on 18 statements pertaining to wound closure and incision management in THA procedures. One notable recommendation cited for at-risk patients was the use of NPWT over other...
An international panel of 20...
02/12/2024
Wound Care
News
02/12/2024
Biocomposites announces the initiation of 2 Phase II clinical trials; the BLADE-VG2 and BLADE-OPU2 trials will investigate STIMULAN VG for patients with diabetic foot osteomyelitis and stage IV pressure ulcers. Clinical Trial Arena
Biocomposites announces the initiation of 2 Phase II clinical trials; the BLADE-VG2 and BLADE-OPU2 trials will investigate STIMULAN VG for patients with diabetic foot osteomyelitis and stage IV pressure ulcers. Clinical Trial Arena
Biocomposites announces the...
02/12/2024
Wound Care
News
02/12/2024
StimLab announced FDA 510(k) clearance for Corplex P, a particulate device derived from human umbilical cord extracellular matrix (ECM). StimLabs is the first company ever to receive a wound care 510(k) clearance for human birth tissue...
StimLab announced FDA 510(k) clearance for Corplex P, a particulate device derived from human umbilical cord extracellular matrix (ECM). StimLabs is the first company ever to receive a wound care 510(k) clearance for human birth tissue...
StimLab announced FDA 510(k)...
02/12/2024
Wound Care
News
02/12/2024
Mölnlycke announced that its near-term greenhouse gas emission reduction targets submitted to the Science Based Targets initiative (SBTi) were validated and deemed to be compliant with all applicable requirements. The company is committed to...
Mölnlycke announced that its near-term greenhouse gas emission reduction targets submitted to the Science Based Targets initiative (SBTi) were validated and deemed to be compliant with all applicable requirements. The company is committed to...
Mölnlycke announced that its...
02/12/2024
Wound Care
News
02/12/2024
There is an expanded reimbursement platform for the Provizio SEM Scanner. In the US, CMS has approved the ICD-10 PCS procedure code, XX2KXP9, for the SEM scanning procedure, effective April 1, 2024. In the UK, the product has been added to...
There is an expanded reimbursement platform for the Provizio SEM Scanner. In the US, CMS has approved the ICD-10 PCS procedure code, XX2KXP9, for the SEM scanning procedure, effective April 1, 2024. In the UK, the product has been added to...
There is an expanded...
02/12/2024
Wound Care
News
02/12/2024
Albert Einstein School of Medicine (Bronx, NY)’s US Patent Application “APPROACH TO SUSTAINED PRODUCTION AND DELIVERY OF NITRIC OXIDE AND S-NITROSOTHIOLS“ was published relating to compositions for generating nitric oxide (NO) as a tx for...
Albert Einstein School of Medicine (Bronx, NY)’s US Patent Application “APPROACH TO SUSTAINED PRODUCTION AND DELIVERY OF NITRIC OXIDE AND S-NITROSOTHIOLS“ was published relating to compositions for generating nitric oxide (NO) as a tx for...
Albert Einstein School of...
02/12/2024
Wound Care

Advertisement

Advertisement

Advertisement